Drug groups face new generics threat

Article reports that drug companies could face competition on their complex biological medicines as soon as 2012, following the release of draft generic guidelines from the European Medicines Agency in November 2010.

EMEA: Press Release, 26.11.10: Draft guideline on biosimilar medicines containing monoclonal antibodies released for consultation http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/11/news_detail_001155.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1

---